Glenview Capital Management
GLENVIEW CAPITAL MANAGEMENT, LLC · NEW YORK, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗Activist Investor
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$5.63B2026 Q3+ $498.4M options (notional, not included)
Positions140
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.55.8%
What Changed This Quarter?
Top Holdings
GPN
Global Payments
9.5%
THC
Tenet Healthcare
8.5%
AMZN
Amazon
6.1%
META
Meta Platforms
5.9%
TMO
Thermo Fisher Scientific
4.9%
TEVA
Teva Pharmaceutical Industries
4.9%
A
Agilent Technologies
4.2%
IWMPUT
Ishares Tr
4.2%
Related managers
Five closest superinvestors by Jaccard overlap of tickers held in the latest quarter (computed nightly).
| Manager | Overlap | Shared holdings |
|---|---|---|
| D.E. Shaw & Co | 11.8% | BSX, EAT, BURL, CI, CVS, CVNA, DHR, DOCU +49 |
| Two Sigma Investments | 10.7% | BSX, CI, CVS, CDNS, CVNA, DHR, DOCU, HUM +52 |
| Alyeska Investment Group | 10.5% | BSX, EAT, BRKR, BURL, CVS, CVNA, DHR, HUM +28 |
| Bridgewater Associates (Ray Dalio) | 10.4% | BSX, CI, CVS, DHR, HUM, KLAC, LLY, MRVL +34 |
| Capital Research Global Investors | 10.4% | CI, CVS, CVNA, DHR, HUM, KLAC, LLY, MRVL +18 |
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.